...
lsb-img

LakeShore Biopharma Co., Ltd, Common Stock

LSB

NAQ

$2.96

+$0.26

(9.63%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$114.29M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
125.55K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.55
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$1.88 L
$11.2 H
$2.96

About LakeShore Biopharma Co., Ltd, Common Stock

LakeShore Biopharma Co., Ltd, a biopharmaceutical company, engages in the discovering, developing, manufacturing, commercializing, and sale of vaccines and therapeutic biologics for infectious diseases and cancer. The company's product pipeline includes YSJA, a conventional rabies vaccine which is in marketed stage; PIKA, a rabies vaccine which are in phase I/III and preclinical trials for the treatment of rabies virus; PIKA YS-ON-001, an immuno-oncology therapeutic that is in phase I trials for the treatment of pancreatic and hepatocellular cancer; PIKA YS-HBV-001, a hepatitis B vaccine that is in phase I trials; PIKA YS-HBV-002, an immune-therapy vaccine which is in IND preclinical trials for the treatment of chronic HBV infection; and PIKA YS-ON-001 and PIKA Influenza Vaccine which are in preclinical trials. It operates in China, Singapore, the United States, and the Philippines. The company was formerly known as YS Biopharma Co., Ltd. and changed its name to LakeShore Biopharma Co., Ltd in May 2024. The company was founded in 2002 and is based in Beijing, China. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameLSBSectorS&P500
1-Week Return18.64%-2.12%-3%
1-Month Return12.98%-3.42%-0.73%
3-Month Return-61.56%-11.13%2.87%
6-Month Return-49.4%-5.74%7.17%
1-Year Return-34.22%3.97%25.31%
3-Year Return-96.95%1.05%28.38%
5-Year Return-68.78%34.37%81.89%

Financials

Mar '21Mar '22Mar '23Mar '24
Total Revenue257.02M502.95M687.20M573.42M[{"date":"2021-03-31","value":37.4,"profit":true},{"date":"2022-03-31","value":73.19,"profit":true},{"date":"2023-03-31","value":100,"profit":true},{"date":"2024-03-31","value":83.44,"profit":true}]
Cost of Revenue59.66M117.07M153.36M117.69M[{"date":"2021-03-31","value":38.9,"profit":true},{"date":"2022-03-31","value":76.33,"profit":true},{"date":"2023-03-31","value":100,"profit":true},{"date":"2024-03-31","value":76.74,"profit":true}]
Gross Profit197.36M385.88M533.84M455.73M[{"date":"2021-03-31","value":36.97,"profit":true},{"date":"2022-03-31","value":72.28,"profit":true},{"date":"2023-03-31","value":100,"profit":true},{"date":"2024-03-31","value":85.37,"profit":true}]
Gross Margin76.79%76.72%77.68%79.48%[{"date":"2021-03-31","value":96.62,"profit":true},{"date":"2022-03-31","value":96.54,"profit":true},{"date":"2023-03-31","value":97.74,"profit":true},{"date":"2024-03-31","value":100,"profit":true}]
Operating Expenses319.68M549.18K647.15M901.56M[{"date":"2021-03-31","value":35.46,"profit":true},{"date":"2022-03-31","value":0.06,"profit":true},{"date":"2023-03-31","value":71.78,"profit":true},{"date":"2024-03-31","value":100,"profit":true}]
Operating Income(125.85M)(549.18K)(139.38M)(445.83M)[{"date":"2021-03-31","value":-12584773700,"profit":false},{"date":"2022-03-31","value":-54918000,"profit":false},{"date":"2023-03-31","value":-13938235100,"profit":false},{"date":"2024-03-31","value":-44583250200,"profit":false}]
Total Non-Operating Income/Expense(78.21M)15.17M(35.82M)(53.71M)[{"date":"2021-03-31","value":-515.45,"profit":false},{"date":"2022-03-31","value":100,"profit":true},{"date":"2023-03-31","value":-236.07,"profit":false},{"date":"2024-03-31","value":-353.93,"profit":false}]
Pre-Tax Income(174.37M)(545.73K)(144.35M)(455.19M)[{"date":"2021-03-31","value":-17437199700,"profit":false},{"date":"2022-03-31","value":-54572700,"profit":false},{"date":"2023-03-31","value":-14434560100,"profit":false},{"date":"2024-03-31","value":-45519347800,"profit":false}]
Income Taxes17.45M4.94M1.13M(21.73M)[{"date":"2021-03-31","value":100,"profit":true},{"date":"2022-03-31","value":28.29,"profit":true},{"date":"2023-03-31","value":6.49,"profit":true},{"date":"2024-03-31","value":-124.49,"profit":false}]
Income After Taxes(191.83M)(5.48M)(145.48M)(433.46M)[{"date":"2021-03-31","value":-19182624200,"profit":false},{"date":"2022-03-31","value":-548284900,"profit":false},{"date":"2023-03-31","value":-14547910500,"profit":false},{"date":"2024-03-31","value":-43346487100,"profit":false}]
Income From Continuous Operations(191.83M)(106.00M)(145.48M)(433.46M)[{"date":"2021-03-31","value":-19182624200,"profit":false},{"date":"2022-03-31","value":-10600440100,"profit":false},{"date":"2023-03-31","value":-14547910500,"profit":false},{"date":"2024-03-31","value":-43346487100,"profit":false}]
Income From Discontinued Operations----[{"date":"2021-03-31","value":"-","profit":true},{"date":"2022-03-31","value":"-","profit":true},{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true}]
Net Income(191.83M)(545.73K)(145.48M)(433.46M)[{"date":"2021-03-31","value":-19182624200,"profit":false},{"date":"2022-03-31","value":-54572700,"profit":false},{"date":"2023-03-31","value":-14547910500,"profit":false},{"date":"2024-03-31","value":-43346487100,"profit":false}]
EPS (Diluted)-0.42-(0.17)[{"date":"2021-03-31","value":"-","profit":true},{"date":"2022-03-31","value":100,"profit":true},{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":-41.15,"profit":false}]

Ratios

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

LSB
ROA (LTM) -13.85%
ROE (LTM) -65.99%

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

LSB
Trailing PE NM
Forward PE NM
P/S (TTM) 0.20
P/B 1.39
EV/R 1.73
EV/Ebitda NM

FAQs

What is LakeShore Biopharma Co., Ltd share price today?

LakeShore Biopharma Co., Ltd (LSB) share price today is $2.96

Can Indians buy LakeShore Biopharma Co., Ltd shares?

Yes, Indians can buy shares of LakeShore Biopharma Co., Ltd (LSB) on Vested. To buy LakeShore Biopharma Co., Ltd from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in LSB stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of LakeShore Biopharma Co., Ltd be purchased?

Yes, you can purchase fractional shares of LakeShore Biopharma Co., Ltd (LSB) via the Vested app. You can start investing in LakeShore Biopharma Co., Ltd (LSB) with a minimum investment of $1.

How to invest in LakeShore Biopharma Co., Ltd shares from India?

You can invest in shares of LakeShore Biopharma Co., Ltd (LSB) via Vested in three simple steps:

  • Click on Sign Up or Invest in LSB stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in LakeShore Biopharma Co., Ltd shares
What is LakeShore Biopharma Co., Ltd 52-week high and low stock price?

The 52-week high price of LakeShore Biopharma Co., Ltd (LSB) is $11.2. The 52-week low price of LakeShore Biopharma Co., Ltd (LSB) is $1.88.

What is LakeShore Biopharma Co., Ltd price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of LakeShore Biopharma Co., Ltd (LSB) is

What is LakeShore Biopharma Co., Ltd price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of LakeShore Biopharma Co., Ltd (LSB) is 1.39

What is LakeShore Biopharma Co., Ltd dividend yield?

The dividend yield of LakeShore Biopharma Co., Ltd (LSB) is 0.00%

What is the Market Cap of LakeShore Biopharma Co., Ltd?

The market capitalization of LakeShore Biopharma Co., Ltd (LSB) is $114.29M

What is LakeShore Biopharma Co., Ltd’s stock symbol?

The stock symbol (or ticker) of LakeShore Biopharma Co., Ltd is LSB

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top